Mandatory Notification of Trade - Flåten
(Oslo, Norway, 26 September 2016) Reference is made to the announcement on 14 September 2016 by Bionor Pharma ASA ("Bionor" or the "Company", ticker "BIONOR") regarding the primary insider notification from certain primary insiders of the Company that have received Subscription Rights in the Rights Issue.
STOCK EXCHANGE ANNOUNCEMENT
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES
Primary insider notification – Gunnar Flåten
Gunnar Flåten, a primary insider of the Company, has today exercised 678,602 Subscription Rights and given his two daughters each 300,000 Subscription Rights and following such transaction holds the following interests in the Company:
in the Rights Issue
|VP Director of Finance||1,496,102||0|
The subscription price for the shares is NOK 0.10 per share.
Unni Hjelmaas, Acting CEO, +47 915 19 651, email@example.com
Jens Krøis, CFO, +45 208 01 668, firstname.lastname@example.org
Link to announcement in pdf